Our findings demonstrated a significant reduction in VEGFA and bFGF expression in PKN2‐overexpressing colon cancer cells compared to control cells, while other proangiogenic factors remained unchanged (Figure 3A). The gene discussed is FGF2; the disease is malignant colon neoplasm.